Japanese Renewable Energy Stock News

Nomura Holdings (TSE:8604) has wrapped up FY 2026 with fourth quarter revenue of ¥577,181 million (¥577.2 billion) and basic EPS of ¥25.29, alongside trailing twelve month EPS of ¥123.08 and net income of ¥362,129 million. The company has seen revenue move from ¥452,735 million in Q4 FY 2025 to ¥577,181 million in Q4 FY 2026, while trailing twelve month EPS has shifted from ¥115.30 to ¥123.08. These figures give investors a clearer view of how the top and bottom lines are tracking into the...

It looks like OPTEX GROUP Company, Limited ( TSE:6914 ) is about to go ex-dividend in the next 4 days. The ex-dividend...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Greens...

Computer Institute of Japan, Ltd. ( TSE:4826 ) is about to trade ex-dividend in the next 4 days. The ex-dividend date...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hamai...

Fullcast Holdings Co., Ltd. ( TSE:4848 ) is about to trade ex-dividend in the next 4 days. The ex-dividend date...

It looks like THK Co., Ltd. ( TSE:6481 ) is about to go ex-dividend in the next four days. The ex-dividend date is...

It looks like Japan Resistor Mfg. Co., Ltd. ( TSE:6977 ) is about to go ex-dividend in the next four days. The...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Readers hoping to buy Noritsu Koki Co., Ltd. ( TSE:7744 ) for its dividend will need to make their move shortly, as the...

Shimano Inc. ( TSE:7309 ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is usually set to be two...

Readers hoping to buy Japan Tobacco Inc. ( TSE:2914 ) for its dividend will need to make their move shortly, as the...

Readers hoping to buy Sumitomo Forestry Co., Ltd. ( TSE:1911 ) for its dividend will need to make their move shortly...

It looks like Yamaha Motor Co., Ltd. ( TSE:7272 ) is about to go ex-dividend in the next four days. The ex-dividend...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Shiseido...

Asahi Group Holdings, Ltd. recently lowered its 2025 earnings guidance, citing weaker revenue linked to cyberattack-driven system failures in Japan, higher raw material costs, impairment losses and expenses related to system disruptions. In parallel, Asahi entered a franchising alliance with India-based Varun Beverages to launch CALPIS-branded ready-to-drink dairy beverages in India from the second half of 2026, highlighting a push to expand its non-alcohol portfolio in a major emerging...

Earlier in June 2026, Trend Micro’s TrendAI™ unit announced it had joined OpenAI’s Daybreak Cyber Partner Program, gaining access to frontier AI models to power autonomous triage and vulnerability intelligence within its Vision One™ security platform. This collaboration could materially enhance TrendAI™’s threat research and zero‑day disclosure capabilities by feeding OpenAI-powered insights directly into its global threat intelligence network and Zero Day Initiative bug bounty...

The Pax Silica pact is reshaping how governments think about technology supply chains, and that shift is already feeding into stock selection. With more countries joining the US-led effort to reduce reliance on Chinese AI related inputs, attention is turning to companies that help secure chips, materials, and infrastructure for future AI demand. This article focuses on three stocks from the AI Supply Chain Beneficiaries screener that appear closely tied to the themes in the latest Pax Silica...

Sanrio Company (TSE:8136) has reported its FY 2026 results with fourth quarter revenue of ¥50.9b and basic EPS of ¥9.02, while trailing twelve month EPS stands at ¥45.33 on revenue of ¥194.1b and net income of ¥54.6b, alongside earnings growth of 30.9% over the past year. Over recent periods, the company has seen revenue move from ¥132.3b and EPS of ¥29.83 on a trailing basis in FY 2025 Q3 to ¥194.1b and EPS of ¥45.33 by FY 2026 Q4. This sets the backdrop for a story where healthy margins,...

If you are wondering whether ARCHION at ¥285 is priced attractively or not, looking at how the market currently values the stock is a useful place to start. The share price has fallen 4.4% over the past week, 29.3% over the past month and is down 21.3% over the last year, which may change how investors think about both its potential and its risks. Recent coverage around ARCHION has focused on its share price performance and how investors are reassessing the stock after this extended period...

As global markets navigate a complex landscape marked by steady interest rates from the Federal Reserve and a significant rate hike by the Bank of Japan, major U.S. indices like the Nasdaq Composite and Russell 2000 have shown resilience with notable gains. In this environment, identifying high-growth tech stocks involves looking for companies that can capitalize on technological advancements and maintain robust performance despite potential economic headwinds and shifting monetary policies.

Nippon Shinyaku Co., Ltd. has entered into a Sponsored Research Agreement with Boston Children's Hospital to co-develop innovative neurology drugs, building on their earlier collaboration and leveraging the NS Pharma Innovation Research Partnering team in Cambridge, MA. This alliance signals Nippon Shinyaku’s intent to deepen its presence in neurology by pairing hospital-based scientific discovery with its own drug development capabilities to address unmet patient needs. We’ll examine how...

Why Kobe Bussan’s Latest Earnings Matter For Investors Kobe Bussan (TSE:3038) has attracted fresh attention after reporting half year earnings to April 30, 2026, with sales of ¥286,172 million and net income of ¥16,501 million compared with the previous year’s period. See our latest analysis for Kobe Bussan. The latest half-year earnings have arrived against a weak share price backdrop for Kobe Bussan, with the stock at ¥2,604.5 after a 1-year total shareholder return that declined 42.03% and...

In June 2026, VolitionRx Limited announced it had entered into a collaboration with Sysmex Corporation to optimize VolitionRx’s Nu.Q NETs H3.1 assay on Sysmex’s platform, following successful transfer of the assay and with a focus on diseases linked to NETosis. The agreement opens access to a very large US$3.80 billion total addressable market for the Nu.Q NETs assay, which could broaden Sysmex’s role in specialized diagnostics. Next, we examine how integrating the Nu.Q NETs assay into...